CancerNCT07769931
Effect of Pecha Kucha-Based Education on Symptom Management and Quality of Life in Patients Receiving Chemotherapy
A study testing PechaKucha-Based Symptom Management Education and Routine/Standard Patient Education in people with Cancer and Neoplams, run by Istanbul Aydın University at 1 site in Turkey (Türkiye).
Trial summary
This randomized controlled study aims to evaluate the effect of education delivered using the PechaKucha method on symptom management and quality of life in patients receiving chemotherapy. Participants will be randomly assigned to either an intervention group or a control group. Read more about this study
- Who is it for?
- Ages 18 years and older
- What is being tested?
- PechaKucha-Based Symptom Management Education and Routine/Standard Patient Education
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 140 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 3 Jun 2026to 30 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Willing to participate in the study.
- Currently receiving treatment in the chemotherapy unit.
- Aged 18 years or older, willing to participate, and able to communicate effectively.
Who cannot join
- Being under 18 years of age.
- Having cognitive or communication difficulties.
- Having a visual or hearing impairment.
- Being in an advanced or terminal stage of the disease.
- Having a physical or psychological condition that prevents active participation in the educational process.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
SBÜ Kanuni Sultan Süleyman E.A.H
Istanbul, Istanbul, 34520
Asiye TAN, Ph D, +90 05055675275, asiyetan@aydin.edu.tr
Dilek Yıldırım, Ph D, +90 05331421987, dilekyildirim@aydin.edu.tr
About this study
Official title: The Effect of Education Provided Using the PechaKucha Method on Symptom Management and Quality of Life in Patients Receiving Chemotherapy
This randomized controlled study aims to evaluate the effect of education delivered using the PechaKucha method on symptom management and quality of life in patients receiving chemotherapy. Participants will be randomly assigned to either an intervention group or a control group.
Participants in the intervention group will receive individual education on symptom management during chemotherapy using the PechaKucha method. The education will be delivered as a video presentation consisting of 20 visual slides and lasting 6 minutes and 40 seconds. Participants in the control group will receive routine/standard patient education.
Symptom severity and quality of life will be assessed before the education and one week after the intervention using the Edmonton Symptom Assessment System (ESAS) and the EQ-5D. The study will compare changes in symptom severity and quality of life between the intervention and control groups to determine whether PechaKucha-based education is effective in supporting symptom management and quality of life among patients receiving chemotherapy.
Read the detailed description
This randomized controlled experimental study is designed to evaluate the effect of education delivered using the PechaKucha method on symptom management and quality of life in patients receiving chemotherapy. The study is being conducted in the Chemotherapy Unit of Health Sciences University Kanuni Sultan Süleyman Training and Research Hospital, with participant enrollment beginning in June 2026.
Participants will be assigned to an intervention group or a control group. Participants in the intervention group will receive individual education on "Symptom Management During Chemotherapy," delivered by the researchers using the PechaKucha method. The educational intervention will be presented as a video consisting of 20 visual slides with a total duration of 6 minutes and 40 seconds. The educational content addresses common chemotherapy-related symptoms and problems, including pain, nausea, anemia, fatigue, diarrhea, constipation, risk of infection, anxiety, depression, mucositis, and alopecia. Participants in the control group will receive routine/standard patient education.
Data will be collected through face-to-face interviews. At baseline, participants in both groups will complete the Patient Information Form, the Edmonton Symptom Assessment System (ESAS), and the EQ-5D. One week after the intervention, the ESAS and EQ-5D will be administered again to participants in both groups. The Patient Information Form, which is used to obtain demographic and clinical information, will be administered only at baseline.
Between-group comparisons will be performed using the independent-samples t-test or Mann-Whitney U test, as appropriate. Within-group pretest-posttest comparisons will be performed using the paired-samples t-test or Wilcoxon signed-rank test, as appropriate. Statistical significance will be set at p < 0.05.
Before participation, individuals will receive written and verbal information about the study, and informed consent will be obtained from all participants.
- Being tested
- PechaKucha-Based Symptom Management Education, Routine/Standard Patient Education
- Keywords
- cemoteraphy, PechaKucha, Patient Education, Symptom Management, Quality of Life, Oncology Nursing
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PechaKucha-Based Symptom Management EducationBehavioural
The intervention consists of individual education on symptom management during chemotherapy delivered by the researchers using the PechaKucha method. The education is provided as a video presentation consisting of 20 visual slides, with each slide displayed for 20 seconds, for a total duration of 6 minutes and 40 seconds. The educational content addresses pain, nausea, anemia, fatigue, diarrhea, constipation, risk of infection, anxiety, depression, mucositis, and alopecia.
Routine/Standard Patient EducationBehavioural
Participants assigned to the control group will receive routine/standard patient education provided as part of usual care in the chemotherapy unit. This education does not include the PechaKucha-based symptom management education provided to the intervention group.
| Study group | Role | What they receive |
|---|---|---|
| PechaKucha-Based Education Group | Experimental | Participants in this arm will receive individual education on "Symptom Management During Chemotherapy" delivered by the researchers using the PechaKucha method. The education will be provided as a video presentation consisting of 20 visual slides with a total duration of 6 minutes and 40 seconds. The educational content covers pain, nausea, anemia, fatigue, diarrhea, constipation, risk of infection, anxiety, depression, mucositis, and alopecia. Receives: Behavioral: PechaKucha-Based Symptom Management Education |
| Routine/Standard Education Group | Active comparator | Participants in this arm will receive routine/standard patient education provided as part of usual care in the chemotherapy unit. No PechaKucha-based education will be provided to participants in this group. Receives: Behavioral: Routine/Standard Patient Education |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Symptom Severity Assessed by the Edmonton Symptom Assessment System (ESAS)
The Edmonton Symptom Assessment System (ESAS) will be used to assess symptom severity in patients receiving chemotherapy. Participants rate the severity of each symptom on a numerical scale, with higher scores indicating greater symptom severity. The intervention group will receive symptom management education using the PechaKucha presentation format, whereas the control group will receive the same educational content using a conventional teaching method. Both groups will also receive a brochure summarizing the educational content. ESAS will be administered to both groups at baseline and one week after the intervention. Changes in symptom severity from baseline will be compared between the groups.
Measured: Baseline (before the intervention) and one week after the intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Aug 2026
- Study start3 Jun 2026
- Primary completion30 Dec 2026 (estimated)
- Study completion30 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- "Participants will be assigned to one of two parallel groups: an intervention group receiving PechaKucha-based education on symptom management during chemotherapy and a control group receiving routine/standard patient education. Outcomes will be assessed at baseline and after the intervention."
- Masking
- None (open label)
- Enrolment
- 140 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Istanbul Aydın University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Asiye TAN, Istanbul Aydın University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07769931
- Sponsor's protocol ID
- 240/2025
- Status last verified
- Aug 2026
- First submitted
- 13 Aug 2026
- Last updated
- 3 Nov 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: There is no plan to share individual participant data (IPD).
Study at a glance
From the registry record, last updated by the sponsor on 3 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Education Provided Using the PechaKucha Method on Symptom Management and Quality of Life in Patients Receiving Chemotherapy
- ClinicalTrials.gov ID
- NCT07769931
- Acronym / sponsor ID
- 240/2025
- Keywords
- cemoteraphy, PechaKucha, Patient Education, Symptom Management, Quality of Life, Oncology Nursing
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 140 participants (estimated)
- Lead sponsor
- Istanbul Aydın UniversityUniversity, hospital or other
- Study start
- 3 Jun 2026 (actual)
- Primary completion
- 30 Dec 2026 (estimated)
- Study completion
- 30 Dec 2026 (estimated)
- First posted
- 18 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled study aims to evaluate the effect of education delivered using the PechaKucha method on symptom management and quality of life in patients receiving chemotherapy. Participants will be randomly assigned to either an intervention group or a control group.
Participants in the intervention group will receive individual education on symptom management during chemotherapy using the PechaKucha method. The education will be delivered as a video presentation consisting of 20 visual slides and lasting 6 minutes and 40 seconds. Participants in the control group will receive routine/standard patient education.
Symptom severity and quality of life will be assessed before the education and one week after the intervention using the Edmonton Symptom Assessment System (ESAS) and the EQ-5D. The study will compare changes in symptom severity and quality of life between the intervention and control groups to determine whether PechaKucha-based education is effective in supporting symptom management and quality of life among patients receiving chemotherapy.
Detailed description
This randomized controlled experimental study is designed to evaluate the effect of education delivered using the PechaKucha method on symptom management and quality of life in patients receiving chemotherapy. The study is being conducted in the Chemotherapy Unit of Health Sciences University Kanuni Sultan Süleyman Training and Research Hospital, with participant enrollment beginning in June 2026.
Participants will be assigned to an intervention group or a control group. Participants in the intervention group will receive individual education on "Symptom Management During Chemotherapy," delivered by the researchers using the PechaKucha method. The educational intervention will be presented as a video consisting of 20 visual slides with a total duration of 6 minutes and 40 seconds. The educational content addresses common chemotherapy-related symptoms and problems, including pain, nausea, anemia, fatigue, diarrhea, constipation, risk of infection, anxiety, depression, mucositis, and alopecia. Participants in the control group will receive routine/standard patient education.
Data will be collected through face-to-face interviews. At baseline, participants in both groups will complete the Patient Information Form, the Edmonton Symptom Assessment System (ESAS), and the EQ-5D. One week after the intervention, the ESAS and EQ-5D will be administered again to participants in both groups. The Patient Information Form, which is used to obtain demographic and clinical information, will be administered only at baseline.
Between-group comparisons will be performed using the independent-samples t-test or Mann-Whitney U test, as appropriate. Within-group pretest-posttest comparisons will be performed using the paired-samples t-test or Wilcoxon signed-rank test, as appropriate. Statistical significance will be set at p < 0.05.
Before participation, individuals will receive written and verbal information about the study, and informed consent will be obtained from all participants.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- "Participants will be assigned to one of two parallel groups: an intervention group receiving PechaKucha-based education on symptom management during chemotherapy and a control group receiving routine/standard patient education. Outcomes will be assessed at baseline and after the intervention."
| Arm | Type | Receives |
|---|---|---|
| PechaKucha-Based Education Group | Experimental | Behavioral: PechaKucha-Based Symptom Management EducationParticipants in this arm will receive individual education on "Symptom Management During Chemotherapy" delivered by the researchers using the PechaKucha method. The education will be provided as a video presentation consisting of 20 visual slides with a total duration of 6 minutes and 40 seconds. The educational content covers pain, nausea, anemia, fatigue, diarrhea, constipation, risk of infection, anxiety, depression, mucositis, and alopecia. |
| Routine/Standard Education Group | Active comparator | Behavioral: Routine/Standard Patient EducationParticipants in this arm will receive routine/standard patient education provided as part of usual care in the chemotherapy unit. No PechaKucha-based education will be provided to participants in this group. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Willing to participate in the study.
- Currently receiving treatment in the chemotherapy unit.
- Aged 18 years or older, willing to participate, and able to communicate effectively.
Key exclusion criteria (5 listed)
- Being under 18 years of age.
- Having cognitive or communication difficulties.
- Having a visual or hearing impairment.
- Being in an advanced or terminal stage of the disease.
- Having a physical or psychological condition that prevents active participation in the educational process.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PechaKucha-Based Symptom Management EducationThe intervention consists of individual education on symptom management during chemotherapy delivered by the researchers using the PechaKucha method. The education is provided as a video presentation consisting of 20 visual slides, with each slide displayed for 20 seconds, for a total duration of 6 minutes and 40 seconds. The educational content addresses pain, nausea, anemia, fatigue, diarrhea, constipation, risk of infection, anxiety, depression, mucositis, and alopecia. | Behavioural | PechaKucha-Based Education Group |
| Routine/Standard Patient EducationParticipants assigned to the control group will receive routine/standard patient education provided as part of usual care in the chemotherapy unit. This education does not include the PechaKucha-based symptom management education provided to the intervention group. | Behavioural | Routine/Standard Education Group |
Primary outcome
Change in Symptom Severity Assessed by the Edmonton Symptom Assessment System (ESAS)
Time frame: Baseline (before the intervention) and one week after the intervention
The Edmonton Symptom Assessment System (ESAS) will be used to assess symptom severity in patients receiving chemotherapy. Participants rate the severity of each symptom on a numerical scale, with higher scores indicating greater symptom severity. The intervention group will receive symptom management education using the PechaKucha presentation format, whereas the control group will receive the same educational content using a conventional teaching method. Both groups will also receive a brochure summarizing the educational content. ESAS will be administered to both groups at baseline and one week after the intervention. Changes in symptom severity from baseline will be compared between the groups.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Nov 2026.
- Individual participant dataSharing planned: No. There is no plan to share individual participant data (IPD).
Related trials for Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing PechaKucha-Based Symptom Management Education and Routine/Standard Patient Education in people with Cancer and Neoplams, run by Istanbul Aydın University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 3 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Asiye TAN, Ph D (05055675275, asiyetan@aydin.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Symptom Severity Assessed by the Edmonton Symptom Assessment System (ESAS) (time frame: Baseline (before the intervention) and one week after the intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2026.